1. Every potential registrant of a non-phase-in substance, or potential registrant of a phase-in substance who has not
pre-registered in accordance with Article
28, shall inquire from the
Agency whether a
registration has already been submitted for the same substance. He shall submit all the following information to the
Agency with the inquiry:
(a) his identity as specified in Section 1 of Annex
VI, with the exception of the use sites;
(b) the identity of the substance, as specified in Section 2 of Annex
VI;
(c) which information requirements would require new
studies involving vertebrate animals to be carried out by him;
(d) which information requirements would require other new
studies to be carried out by him.
2. If the same substance has previously not been
registered, the
Agency shall inform the potential registrant accordingly.
3. If the same substance has previously been
registered less than 12 years earlier, the
Agency shall inform the potential registrant without delay of the names and addresses of the previous registrant(s) and of the relevant
summaries or robust
study summaries, as the case may be, already submitted by them.
Studies involving vertebrate animals shall not be repeated.
The
Agency shall simultaneously inform the previous registrants of the name and address of the potential registrant. The available
studies shall be shared with the potential registrant in accordance with Article
27.
4. If several potential registrants have made an inquiry in respect of the same substance, the
Agency shall inform all potential registrants without delay of the name and address of the other potential registrants.